» Articles » PMID: 28750929

Blood Pressure Parameters Are Associated with All-cause and Cause-specific Mortality in Chronic Kidney Disease

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2017 Jul 29
PMID 28750929
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Previous observational studies reported J or U-shaped associations between blood pressure parameters and mortality in patients with chronic kidney disease (CKD). Here we examined the associations of different blood pressure levels with various causes of death in a CKD population that included patients with eGFR 15-59 ml/min/1.73 m with underlying hypertension receiving at least one antihypertensive agent. We obtained data on date and cause of death from State Department of Health mortality files and classified deaths into three categories: cardiovascular, malignancy-related, and non-cardiovascular/non-malignancy related. Cox models were fitted for overall mortality, and separate competing risk regression models for each major cause of death category, to evaluate their associations with various systolic and diastolic blood pressures. During a median follow-up of 3.9 years, 13,332 of 45,412 patients died. Systolic blood pressures under 100, 100-109, 110-119, and over 150 (vs. 130-139 mm Hg) were associated with higher all-cause and cardiovascular mortality. Systolic blood pressures under 100 mm Hg and 100-109 were associated with higher non-cardiovascular/non-malignancy related mortality. Diastolic blood pressures under 50 and 50-59 (vs. 70-79 mm Hg) were associated with higher all-cause and non-cardiovascular/non-malignancy-related mortality while diastolic blood pressures over 90 mm Hg was associated with higher cardiovascular but lower non-cardiovascular/non-malignancy related mortality. Thus, in a non-dialysis dependent CKD population, systolic blood pressures under 110 and over 150 mm Hg were associated with cardiovascular and non-cardiovascular/non-malignancy related deaths. However, diastolic blood pressure under 60 mm Hg was associated in contrast with all-cause mortality and non-cardiovascular/non-malignancy-related deaths.

Citing Articles

Ambulatory Blood Pressure Monitoring During 52 Hours in Patients With Chronic Kidney Disease and Haemodialysis Treatment-An Exploratory Pilot Study.

Stenberg J, Sandberg O, Marttala K, Svensson M J Ren Care. 2025; 51(1):e70009.

PMID: 39905984 PMC: 11795226. DOI: 10.1111/jorc.70009.


Blood pressure control in diabetic kidney disease: a post-hoc analysis of the FANTASTIC trial.

Park C, Hong S, Kim S, Shin S, Kim D, Lee J Clin Hypertens. 2024; 30(1):20.

PMID: 39085979 PMC: 11293031. DOI: 10.1186/s40885-024-00280-x.


Mortality prediction with adaptive feature importance recalibration for peritoneal dialysis patients.

Ma L, Zhang C, Gao J, Jiao X, Yu Z, Zhu Y Patterns (N Y). 2023; 4(12):100892.

PMID: 38106617 PMC: 10724364. DOI: 10.1016/j.patter.2023.100892.


An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease.

Sun D, Targher G, Byrne C, Wheeler D, Wong V, Fan J Hepatobiliary Surg Nutr. 2023; 12(3):386-403.

PMID: 37351121 PMC: 10282675. DOI: 10.21037/hbsn-22-421.


Systolic blood pressure, low-density lipoprotein cholesterol levels, and adverse kidney outcome: results from KNOW-CKD.

Kim K, Koh H, Kim H, Park J, Yoo T, Kang S Hypertens Res. 2023; 46(6):1395-1406.

PMID: 36849581 DOI: 10.1038/s41440-023-01230-0.


References
1.
Kovesdy C, Bleyer A, Molnar M, Ma J, Sim J, Cushman W . Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med. 2013; 159(4):233-42. PMC: 4155539. DOI: 10.7326/0003-4819-159-4-201308200-00004. View

2.
Bansal N, McCulloch C, Lin F, Robinson-Cohen C, Rahman M, Kusek J . Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease. Kidney Int. 2016; 90(6):1348-1356. PMC: 5123948. DOI: 10.1016/j.kint.2016.08.009. View

3.
Cushman W, Evans G, Byington R, Goff Jr D, Grimm Jr R, Cutler J . Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362(17):1575-85. PMC: 4123215. DOI: 10.1056/NEJMoa1001286. View

4.
Peralta C, Norris K, Li S, Chang T, Tamura M, Jolly S . Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2012; 172(1):41-7. PMC: 3417125. DOI: 10.1001/archinternmed.2011.619. View

5.
Chiang H, Jia-Jung Lee , Chiu Y, Tsai J, Hung C, Hwang S . Systolic blood pressure and outcomes in stage 3-4 chronic kidney disease patients: evidence from a Taiwanese cohort. Am J Hypertens. 2014; 27(11):1396-407. PMC: 4263936. DOI: 10.1093/ajh/hpu056. View